Field | Row 1 |
---|---|
adsh | 0000950170-25-061007 |
cik | 1018979 |
name | AMERISAFE INC |
sic | 6331 |
countryba | US |
stprba | LA |
cityba | DERIDDER |
zipba | 70634 |
bas1 | 2301 HIGHWAY 190 WEST |
bas2 | |
baph | 337-463-9052 |
countryma | US |
stprma | LA |
cityma | DERIDDER |
zipma | 70634 |
mas1 | 2301 HIGHWAY 190 WEST |
mas2 | |
countryinc | US |
stprinc | TX |
ein | 752069407 |
former | |
changed | |
afs | 1-LAF |
wksi | 0 |
fye | 1231 |
form | 10-Q |
period | 20250331 |
fy | 2025 |
fp | Q1 |
filed | 20250430 |
accepted | 2025-04-30 16:01:00.0 |
prevrpt | 0 |
detail | 1 |
instance | amsf-20250331_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0000950170-25-061007 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 371000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Available For Sale Debt Securities Amortized Cost Basis | 4545000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 148206000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S States And Political Subdivisions; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 13950000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 155666000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S States And Political Subdivisions; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Cash And Cash Equivalents At Carrying Value | 44753000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 33375000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -5307000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Common Stock Dividends Per Share Declared | 0.3900 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Common Stock Shares Outstanding | 20733166.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061007 | 20250331 | Debt Securities Available For Sale Allowance For Credit Loss | 0.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Debt Securities Held To Maturity Allowance For Credit Loss | 116000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Debt Securities Held To Maturity Allowance For Credit Loss | 29000.0000 | USD | 0 | us-gaap/2024 | Investment Type= U S States And Political Subdivisions; | ||
0000950170-25-061007 | 20241231 | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | 413061000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | 8500000.0000 | USD | 0 | us-gaap/2024 | Investment Type= U S Treasury And Government; | ||
0000950170-25-061007 | 20241231 | Equity Securities Fv Ni | 58629000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure; | ||
0000950170-25-061007 | 20250331 | Equity Securities Fv Ni | 55476000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Equity Securities Fv Ni Cost | 36020000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 8127000.0000 | USD | 0 | us-gaap/2024 | Investment Type= U S Treasury And Government; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 2595000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 2595000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 347914000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S States And Political Subdivisions; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 347914000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S States And Political Subdivisions; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
0000950170-25-061007 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 20745000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -234000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Increase Decrease In Deferred Policy Acquisition Costs | 1271000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Increase Decrease In Premiums Receivable | 14079000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Increase Decrease In Unearned Premiums | 7703000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Investments | 788778000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Investments | 781012000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Liabilities And Stockholders Equity | 1156717000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Marketable Securities | 11569000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure; | ||
0000950170-25-061007 | 20241231 | Other Assets | 11297000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Other Assets | 6876000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Other Liabilities | 37858000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Payments To Acquire Held To Maturity Securities | 3320000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Payments To Acquire Property Plant And Equipment | 2000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Policyholder Contract Deposits | 33867000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities | 12692000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Provision For Investment Related Credit Loss Benefit Expense | -17000.0000 | USD | 1 | 0000950170-25-061007 | |||
0000950170-25-061007 | 20240331 | Realized Investment Gains Losses | -222000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Reinsurance Recoverables Allowance | 300000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Retained Earnings Accumulated Deficit | 84105000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Stockholders Equity | 222443000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061007 | 20250331 | Accrued Investment Income Receivable | 7747000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 371000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061007 | 20241231 | Assets | 1157791000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Assets | 1156717000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Available For Sale Debt Securities Amortized Cost Basis | 156488000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= U S States And Political Subdivisions; | ||
0000950170-25-061007 | 20250331 | Available For Sale Debt Securities Amortized Cost Basis | 14886000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= U S Treasury And Government; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 4059000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 148206000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S States And Political Subdivisions; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 293800000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 140910000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Corporate Debt Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 300579000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 4003000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; | ||
0000950170-25-061007 | 20241231 | Common Stock Shares Issued | 20733166.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20231231 | Common Stock Shares Outstanding | 20704448.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061007 | 20241231 | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | 33763000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Corporate Debt Securities; | ||
0000950170-25-061007 | 20241231 | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | 8478000.0000 | USD | 0 | us-gaap/2024 | Investment Type= U S Treasury And Government; | ||
0000950170-25-061007 | 20250331 | Deferred Policy Acquisition Costs | 20422000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Dividends Common Stock | 7101000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061007 | 20250331 | Equity Securities Fv Ni | 55476000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= Domestic Common Stock; | ||
0000950170-25-061007 | 20240331 | Finance Lease Principal Payments | 21000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Funds Held Under Reinsurance Agreements Liability | 33761000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 391594000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 2643000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 385981000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 8302000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S Treasury Securities; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 8302000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 377679000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
0000950170-25-061007 | 20250331 | Income Tax Expense Benefit | 2272000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Increase Decrease In Accrued Investment Income Receivable | -24000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Increase Decrease In Accrued Investment Income Receivable | 420000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Increase Decrease In Other Operating Assets | -1772000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Labor And Related Expense | 7505000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Liability For Claims And Claims Adjustment Expense | 639965000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Marketable Securities | 9338000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Net Income Loss | 16925000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -1546000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20240331 | Policyholder Dividends | 1072000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Premiums Receivable Allowance For Doubtful Accounts | 4129000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Premiums Written Gross | 80074000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Premiums Written Net | 76148000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Profit Loss | 16925000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Realized Investment Gains Losses | -6000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20231231 | Stockholders Equity | 222078000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061007 | 20241231 | Stockholders Equity | 84105000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061007 | 20250331 | Stockholders Equity | 85600000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061007 | 20250331 | Treasury Stock Common Shares | 1682851.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Treasury Stock Value | 42052000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Underwriting And Certain Other Operating Costs | 5311000.0000 | USD | 1 | 0000950170-25-061007 | |||
0000950170-25-061007 | 20250331 | Underwriting And Certain Other Operating Costs | 6260000.0000 | USD | 1 | 0000950170-25-061007 | |||
0000950170-25-061007 | 20250331 | Unearned Premiums | 132646000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Available For Sale Debt Securities Amortized Cost Basis | 163615000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= U S States And Political Subdivisions; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 141535000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Corporate Debt Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 148206000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= U S States And Political Subdivisions; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 155666000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S States And Political Subdivisions; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 14147000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S Treasury Securities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 155666000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= U S States And Political Subdivisions; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 14147000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= U S Treasury And Government; | ||
0000950170-25-061007 | 20241231 | Cash And Cash Equivalents At Carrying Value | 44045000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 44045000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Comprehensive Income Net Of Tax | 10555000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | 9000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Asset Backed Securities; | ||
0000950170-25-061007 | 20250331 | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | 28039000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Corporate Debt Securities; | ||
0000950170-25-061007 | 20240331 | Earnings Per Share Basic | 0.8900 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Equity Securities Fv Ni | 58629000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= Domestic Common Stock; | ||
0000950170-25-061007 | 20250331 | Equity Securities Fv Ni | 55476000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Common Stock; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 8127000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S Treasury Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 399721000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 399241000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure; | ||
0000950170-25-061007 | 20250331 | Income Tax Receivable | 96000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -868000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | 4141000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Increase Decrease Reinsurance Balances | 2496000.0000 | USD | 1 | 0000950170-25-061007 | |||
0000950170-25-061007 | 20240331 | Insurance Commissions | 5882000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Labor And Related Expense | 8284000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Net Cash Provided By Used In Financing Activities | -7445000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Net Cash Provided By Used In Investing Activities | -5717000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Net Cash Provided By Used In Investing Activities | 9945000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Net Income Loss | 16925000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061007 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -1546000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Other Liabilities | 38409000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Payments Of Dividends Common Stock | 7075000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Payments To Acquire Available For Sale Securities Debt | 8320000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Policyholder Benefits And Claims Incurred Net | 39991000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Property Plant And Equipment Net | 5887000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Share Based Compensation | 1073000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20231231 | Stockholders Equity | 292451000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Stockholders Equity | 124113000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061007 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -7269000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -8875000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Additional Paid In Capital Common Stock | 223956000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 141535000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Corporate Debt Securities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 14147000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 314726000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure; | ||
0000950170-25-061007 | 20240331 | Change In Investment Related Allowance For Credit Losses | -17000.0000 | USD | 1 | 0000950170-25-061007 | |||
0000950170-25-061007 | 20250331 | Change In Investment Related Allowance For Credit Losses | -16000.0000 | USD | 1 | 0000950170-25-061007 | |||
0000950170-25-061007 | 20241231 | Common Stock Value | 207000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Debt Securities Held To Maturity Allowance For Credit Loss | 30000.0000 | USD | 0 | us-gaap/2024 | Investment Type= U S States And Political Subdivisions; | ||
0000950170-25-061007 | 20250331 | Debt Securities Held To Maturity Allowance For Credit Loss | 100000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | 368026000.0000 | USD | 0 | us-gaap/2024 | Investment Type= U S States And Political Subdivisions; | ||
0000950170-25-061007 | 20250331 | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | 2696000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; | ||
0000950170-25-061007 | 20240331 | Deferred Income Tax Expense Benefit | -369000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Equity Securities Fv Ni | 58629000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Common Stock; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20241231 | Equity Securities Fv Ni Cost | 36020000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 13000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Asset Backed Securities; | ||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 32670000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Corporate Debt Securities; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 9000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Asset Backed Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 385981000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 27161000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Corporate Debt Securities; | ||
0000950170-25-061007 | 20240331 | Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | -5935000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Increase Decrease In Unearned Premiums | 10720000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Insurance Related Assessments | 14852000.0000 | USD | 0 | 0000950170-25-061007 | |||
0000950170-25-061007 | 20241231 | Liabilities | 900450000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Marketable Securities | 9338000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure; | ||
0000950170-25-061007 | 20240331 | Net Cash Provided By Used In Financing Activities | -7096000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Net Income Loss | -91000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 1606000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Other Income | 210000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Policyholder Contract Deposits | 33462000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Premiums Earned Net | 68446000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Premiums Receivable Allowance For Doubtful Accounts | 4238000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Property Plant And Equipment Net | 5675000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Reinsurance Recoverables | 114278000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Revenues | 80489000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Share Based Compensation | 688000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Stockholders Equity | 301094000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Stockholders Equity | 223956000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061007 | 20250331 | Stockholders Equity | 260813000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Stockholders Equity | 224327000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061007 | 20241231 | Unearned Premiums | 121926000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 19036309.0000 | shares | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Policyholder Benefits And Claims Incurred Net | 40159000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 13950000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S Treasury Securities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 307750000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 4059000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 314726000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 314726000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 140910000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= Corporate Debt Securities; | ||
0000950170-25-061007 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0100 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Common Stock Shares Outstanding | 20704448.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061007 | 20241231 | Common Stock Shares Outstanding | 20733166.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061007 | 20241231 | Premiums Receivable At Carrying Value | 142659000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Common Stock Shares Outstanding | 19050315.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Common Stock Value | 207000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Debt Securities Held To Maturity Allowance For Credit Loss | 86000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Corporate Debt Securities; | ||
0000950170-25-061007 | 20250331 | Deferred Income Tax Expense Benefit | -91000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Depreciation | 328000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Dividends Common Stock | 7454000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Earnings Per Share Basic | 0.4700 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Earnings Per Share Diluted | 0.4700 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 13000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Asset Backed Securities; | ||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 356268000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S States And Political Subdivisions; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 8127000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S Treasury Securities; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 9000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Asset Backed Securities; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 8302000.0000 | USD | 0 | us-gaap/2024 | Investment Type= U S Treasury And Government; | ||
0000950170-25-061007 | 20240331 | Increase Decrease Amounts Held For Others And Policyholder Deposits | 1482000.0000 | USD | 1 | 0000950170-25-061007 | |||
0000950170-25-061007 | 20240331 | Increase Decrease In Deferred Policy Acquisition Costs | 1019000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | -11344000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Insurance Commissions | 6055000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Marketable Securities | 11569000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure; | ||
0000950170-25-061007 | 20240331 | Net Cash Provided By Used In Operating Activities | 7506000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Net Income Loss | -4000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20250331 | Net Investment Income | 6652000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Payments To Acquire Property Plant And Equipment | 746000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Premiums Receivable At Carrying Value | 156746000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Proceeds From Sale And Maturity Of Available For Sale Securities | 24216000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Provision For Investment Related Credit Loss Benefit Expense | -16000.0000 | USD | 1 | 0000950170-25-061007 | |||
0000950170-25-061007 | 20250331 | Realized Investment Gains Losses | 2000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Revenues | 72597000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20231231 | Stockholders Equity | 114289000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061007 | 20240331 | Stockholders Equity | -8740000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20240331 | Stockholders Equity | 207000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061007 | 20250331 | Treasury Stock Common Shares | 1682851.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000950170-25-061007 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 19122168.0000 | shares | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | -519000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Accrued Investment Income Receivable | 7327000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Additional Paid In Capital Common Stock | 224327000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Available For Sale Debt Securities Amortized Cost Basis | 141024000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= Corporate Debt Securities; | ||
0000950170-25-061007 | 20250331 | Available For Sale Debt Securities Amortized Cost Basis | 4406000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 141535000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= Corporate Debt Securities; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 14147000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S Treasury Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20240331 | Benefits Losses And Expenses | 59744000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Common Stock Shares Issued | 20733166.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Common Stock Shares Outstanding | 19050315.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | 399241000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Deferred Income Tax Assets Net | 19448000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Deferred Income Tax Assets Net | 19112000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Depreciation | 214000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Dividends Common Stock | 7101000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Equity Securities Fv Ni Cost | 36020000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= Domestic Common Stock; | ||
0000950170-25-061007 | 20240331 | Equity Securities Fv Ni Unrealized Gain Loss | 4776000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 13000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Asset Backed Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 32670000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Corporate Debt Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 2643000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; | ||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 2643000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 8127000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 9000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Asset Backed Securities; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 27161000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Corporate Debt Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 347914000.0000 | USD | 0 | us-gaap/2024 | Investment Type= U S States And Political Subdivisions; | ||
0000950170-25-061007 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -115000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -6000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20240331 | Income Tax Expense Benefit | 3820000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Income Tax Expense Benefit | -24000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20241231 | Income Tax Receivable | 2180000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Increase Decrease In Other Operating Assets | 724000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Increase Decrease Reinsurance Balances | 2741000.0000 | USD | 1 | 0000950170-25-061007 | |||
0000950170-25-061007 | 20250331 | Insurance Related Assessments | 15888000.0000 | USD | 0 | 0000950170-25-061007 | |||
0000950170-25-061007 | 20250331 | Liabilities | 895904000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Liability For Claims And Claims Adjustment Expense | 668059000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Liability For Claims And Claims Adjustment Expense | 651309000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Net Investment Income | 7366000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 1606000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20241231 | Payable Investment Purchase | 1430000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Payments Of Dividends Common Stock | 7424000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Premiums Earned Net | 68885000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Premiums Written Net | 79605000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities | 16236000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Profit Loss | 8949000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Realized Investment Gains Losses | -115000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20231231 | Stockholders Equity | -7194000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20241231 | Stockholders Equity | -8875000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20241231 | Stockholders Equity | 207000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061007 | 20250331 | Stockholders Equity | -42052000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000950170-25-061007 | 20231231 | Treasury Stock Common Shares | 1569440.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000950170-25-061007 | 20241231 | Treasury Stock Common Shares | 1682851.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000950170-25-061007 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | -261000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Available For Sale Debt Securities Amortized Cost Basis | 318975000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Available For Sale Debt Securities Amortized Cost Basis | 14872000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= U S Treasury And Government; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 13950000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S Treasury Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 307750000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 4003000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 4003000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 708000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 44753000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Debt Securities Held To Maturity Allowance For Credit Loss | 71000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Corporate Debt Securities; | ||
0000950170-25-061007 | 20241231 | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | 13000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Asset Backed Securities; | ||
0000950170-25-061007 | 20241231 | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | 2781000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; | ||
0000950170-25-061007 | 20250331 | Dividends Common Stock | 7454000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061007 | 20241231 | Equity Securities Fv Ni | 58629000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Equity Securities Fv Ni | 58629000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Common Stock; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Equity Securities Fv Ni | 55476000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure; | ||
0000950170-25-061007 | 20250331 | Finance Lease Principal Payments | 21000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Funds Held Under Reinsurance Agreements Liability | 38657000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 399721000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 413061000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 2595000.0000 | USD | 0 | us-gaap/2024 | Investment Type= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; | ||
0000950170-25-061007 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | 11221000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | 2084000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Increase Decrease In Premiums Receivable | 13314000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Liabilities And Stockholders Equity | 1157791000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Marketable Securities | 11569000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Net Income Loss | 8949000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Other Income | 123000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Payable Investment Purchase | 2324000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Payments To Acquire Short Term Investments | 2178000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Premiums Written Gross | 83784000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Proceeds From Sale And Maturity Of Available For Sale Securities | 4209000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Reinsurance Recoverables | 117019000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Reinsurance Recoverables Allowance | 294000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Retained Earnings Accumulated Deficit | 85600000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20231231 | Stockholders Equity | -36929000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000950170-25-061007 | 20240331 | Stockholders Equity | -36929000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000950170-25-061007 | 20240331 | Treasury Stock Common Shares | 1569440.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000950170-25-061007 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 19211282.0000 | shares | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 19154426.0000 | shares | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 365000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 365000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061007 | 20241231 | Available For Sale Debt Securities Amortized Cost Basis | 143070000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= Corporate Debt Securities; | ||
0000950170-25-061007 | 20250331 | Available For Sale Debt Securities Amortized Cost Basis | 323931000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 307750000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 4059000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Mortgage Backed Securities Issued By U S Government Sponsored Enterprises; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 307750000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20241231 | Available For Sale Securities Debt Securities | 13950000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= U S Treasury And Government; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 140910000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Corporate Debt Securities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Available For Sale Securities Debt Securities | 314726000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Estimate Of Fair Value Fair Value Disclosure; | ||
0000950170-25-061007 | 20250331 | Benefits Losses And Expenses | 61376000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 38682000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Ceded Premiums Written | 3926000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Ceded Premiums Written | 4179000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Common Stock Dividends Per Share Declared | 0.3700 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Comprehensive Income Net Of Tax | 15379000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Debt Securities Available For Sale Allowance For Credit Loss | 0.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | 359997000.0000 | USD | 0 | us-gaap/2024 | Investment Type= U S States And Political Subdivisions; | ||
0000950170-25-061007 | 20241231 | Deferred Policy Acquisition Costs | 19151000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20240331 | Earnings Per Share Diluted | 0.8800 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Equity Securities Fv Ni | 58629000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure; | ||
0000950170-25-061007 | 20250331 | Equity Securities Fv Ni | 55476000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Common Stock; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
0000950170-25-061007 | 20250331 | Equity Securities Fv Ni | 55476000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure; | ||
0000950170-25-061007 | 20241231 | Equity Securities Fv Ni Cost | 36020000.0000 | USD | 0 | us-gaap/2024 | Financial Instrument= Domestic Common Stock; | ||
0000950170-25-061007 | 20250331 | Equity Securities Fv Ni Unrealized Gain Loss | -3152000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 32670000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Corporate Debt Securities; | ||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 356268000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S States And Political Subdivisions; | ||
0000950170-25-061007 | 20241231 | Held To Maturity Securities Fair Value | 356268000.0000 | USD | 0 | us-gaap/2024 | Investment Type= U S States And Political Subdivisions; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 27161000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= Corporate Debt Securities; | ||
0000950170-25-061007 | 20250331 | Held To Maturity Securities Fair Value | 8302000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Asset Class= U S Treasury Securities; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; | ||
0000950170-25-061007 | 20250331 | Income Tax Expense Benefit | -2000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Net Unrealized Investment Gain Loss; Reclassification Out Of Accumulated Other Comprehensive Income= Reclassification Out Of Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20250331 | Increase Decrease Amounts Held For Others And Policyholder Deposits | -5301000.0000 | USD | 1 | 0000950170-25-061007 | |||
0000950170-25-061007 | 20231231 | Liability For Claims And Claims Adjustment Expense | 673994000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Marketable Securities | 9338000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Measurement Basis= Carrying Reported Amount Fair Value Disclosure; | ||
0000950170-25-061007 | 20250331 | Net Cash Provided By Used In Operating Activities | -1792000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Net Income Loss | 8949000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061007 | 20240331 | Payments To Acquire Short Term Investments | 38559000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Policyholder Dividends | 634000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061007 | 20231231 | Stockholders Equity | 207000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061007 | 20241231 | Stockholders Equity | 257341000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20241231 | Stockholders Equity | -42052000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
0000950170-25-061007 | 20250331 | Stockholders Equity | -7269000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-061007 | 20250331 | Stockholders Equity | 207000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061007 | 20241231 | Treasury Stock Common Shares | 1682851.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061007 | 20250331 | Treasury Stock Value | 42052000.0000 | USD | 0 | us-gaap/2024 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Debt Securities Available For Sale Allowance For Credit Loss | us-gaap/2024 | 0 | 0 | monetary | I | C | Debt Securities, Available-for-Sale, Allowance for Credit Loss | Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
Deferred Income Tax Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Income Tax Assets, Net | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting. |
Deferred Policy Acquisition Costs | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Policy Acquisition Cost | Amount of deferred policy acquisition cost capitalized on contract remaining in force. |
Equity Securities Fv Ni | us-gaap/2024 | 0 | 0 | monetary | I | D | Equity Securities, FV-NI, Current | Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current. |
Equity Securities Fv Ni Unrealized Gain Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Equity Securities, FV-NI, Unrealized Gain (Loss) | Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
Increase Decrease In Premiums Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Premiums Receivable | The change in the premium receivable balance on the balance sheet. |
Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
Other Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Income | Amount of revenue and income classified as other. |
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities | The cash inflow associated with the maturity, prepayments and calls (requests for early payments) of debt securities designated as held-to-maturity. |
Realized Investment Gains Losses | us-gaap/2024 | 0 | 0 | monetary | D | C | Realized Investment Gains (Losses) | Amount of realized gain (loss) on investment. |
Reinsurance Recoverables Allowance | us-gaap/2024 | 0 | 0 | monetary | I | C | Reinsurance Recoverable, Allowance for Credit Loss | Amount of allowance for credit loss on reinsurance recoverable. |
Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Available For Sale Securities Debt Securities | us-gaap/2024 | 0 | 0 | monetary | I | D | Debt Securities, Available-for-Sale | Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
Common Stock Dividends Per Share Declared | us-gaap/2024 | 0 | 0 | perShare | D | Common Stock, Dividends, Per Share, Declared | Aggregate dividends declared during the period for each share of common stock outstanding. | |
Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Held To Maturity Securities Fair Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Debt Securities, Held-to-Maturity, Fair Value | Fair value of investment in debt security measured at amortized cost (held-to-maturity). |
Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Premiums Written Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Premiums Written, Net | Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums written. |
Reinsurance Recoverables | us-gaap/2024 | 0 | 0 | monetary | I | D | Reinsurance Recoverables, Including Reinsurance Premium Paid | Amount, after valuation allowance, recoverable under reinsurance contracts including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves. |
Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Treasury Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Treasury Stock, Value | The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. |
Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
Increase Decrease Reinsurance Balances | 0000950170-25-061007 | 1 | 0 | monetary | D | D | Increase Decrease Reinsurance Balances | Increase decrease reinsurance balances. |
Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Equity Securities Fv Ni Cost | us-gaap/2024 | 0 | 0 | monetary | I | D | Equity Securities, FV-NI, Cost | Cost of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Excludes equity method investment and investment in equity security without readily determinable fair value. |
Funds Held Under Reinsurance Agreements Liability | us-gaap/2024 | 0 | 0 | monetary | I | C | Funds Held under Reinsurance Agreements, Liability | Amount of funds held as security for payments to be received under reinsurance contracts. |
Income Tax Receivable | us-gaap/2024 | 0 | 0 | monetary | I | D | Income Taxes Receivable | Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable. |
Increase Decrease In Accrued Investment Income Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accrued Investment Income Receivable | The increase (decrease) during the reporting period in investment income that has been earned but not yet received in cash. |
Insurance Commissions | us-gaap/2024 | 0 | 0 | monetary | D | D | Insurance Commissions | The expense incurred by an insurance company to persons or entities for generating or placing insurance or investment contracts with the company, usually determined as a percentage of policy or contract premiums. Excludes advances or draws to be applied against commissions earned. |
Policyholder Benefits And Claims Incurred Net | us-gaap/2024 | 0 | 0 | monetary | D | D | Policyholder Benefits and Claims Incurred, Net | Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred. |
Policyholder Dividends | us-gaap/2024 | 0 | 0 | monetary | D | D | Policyholder Dividends, Expense | Amount of expense for dividends to policyholders. |
Premiums Receivable At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Premiums Receivable, Net | The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts. |
Unearned Premiums | us-gaap/2024 | 0 | 0 | monetary | I | C | Unearned Premiums | Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date. |
Dividends Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Dividends, Common Stock | Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). |
Ceded Premiums Written | us-gaap/2024 | 0 | 0 | monetary | D | D | Ceded Premiums Written | Amount of written premiums ceded to other entities. |
Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Debt Securities, Held-to-Maturity, Excluding Accrued Interest, after Allowance for Credit Loss, Current | Amount excluding accrued interest, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as current. |
Finance Lease Principal Payments | us-gaap/2024 | 0 | 0 | monetary | D | C | Finance Lease, Principal Payments | Amount of cash outflow for principal payment on finance lease. |
Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable | The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes. |
Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve | Amount of increase (decrease) in liability to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date. |
Increase Decrease In Other Operating Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Operating Assets | Amount of increase (decrease) in operating assets classified as other. |
Payments To Acquire Available For Sale Securities Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Debt Securities, Available-for-Sale | Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
Premiums Written Gross | us-gaap/2024 | 0 | 0 | monetary | D | C | Premiums Written, Gross | Amount of direct and assumed premiums written. |
Proceeds From Sale And Maturity Of Available For Sale Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale | Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
Change In Investment Related Allowance For Credit Losses | 0000950170-25-061007 | 1 | 0 | monetary | D | D | Change In Investment Related Allowance For Credit Losses | Change in investment related allowance for credit losses. |
Insurance Related Assessments | 0000950170-25-061007 | 1 | 0 | monetary | I | C | Insurance Related Assessments | Assessments mandated by statute or regulatory authority that is related directly or indirectly to underwriting activities, including pools for self-insurance and excluding premium taxes and income taxes. The funds derived from the assessments generally enable a government guarantor to pay insurance claims in the event that the underwriting insurer is insolvent or otherwise unable to meet its payment obligations. |
Premiums Earned Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Premiums Earned, Net | Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned. |
Benefits Losses And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Benefits, Losses and Expenses | The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs. |
Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
Underwriting And Certain Other Operating Costs | 0000950170-25-061007 | 1 | 0 | monetary | D | D | Underwriting And Certain Other Operating Costs | Costs incurred during the period related to the acquisition or renewal of insurance contracts. Includes general and administrative expenses. |
Accrued Investment Income Receivable | us-gaap/2024 | 0 | 0 | monetary | I | D | Accrued Investment Income Receivable | Interest, dividends, rents, ancillary and other revenues earned but not yet received by the entity on its investments. |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. |
Available For Sale Debt Securities Amortized Cost Basis | us-gaap/2024 | 0 | 0 | monetary | I | D | Debt Securities, Available-for-Sale, Amortized Cost | Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). |
Deferred Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Deferred Income Tax Expense (Benefit) | Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. |
Liability For Claims And Claims Adjustment Expense | us-gaap/2024 | 0 | 0 | monetary | I | C | Liability for Claims and Claims Adjustment Expense | The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date. |
Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities | Amount of investment in marketable security. |
Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Debt Securities Held To Maturity Allowance For Credit Loss | us-gaap/2024 | 0 | 0 | monetary | I | C | Debt Securities, Held-to-Maturity, Allowance for Credit Loss | Amount of allowance for credit loss for debt security measured at amortized cost (held-to-maturity). |
Labor And Related Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Labor and Related Expense | Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. |
Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
Other Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities | Amount of liabilities classified as other. |
Payable Investment Purchase | us-gaap/2024 | 0 | 0 | monetary | I | C | Payable, Investment, Purchase | Amount of payable for purchase of investment. |
Payments To Acquire Held To Maturity Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Held-to-Maturity Securities | Amount of cash outflow through purchase of long-term held-to-maturity securities. |
Premiums Receivable Allowance For Doubtful Accounts | us-gaap/2024 | 0 | 0 | monetary | I | C | Premium Receivable, Allowance for Credit Loss | The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value. |
Increase Decrease Amounts Held For Others And Policyholder Deposits | 0000950170-25-061007 | 1 | 0 | monetary | D | D | Increase Decrease Amounts Held For Others And Policyholder Deposits | Increase decrease amounts held for others and policyholder deposits. |
Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
Increase Decrease In Unearned Premiums | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Unearned Premiums | Amount of increase (decrease) unearned premiums written. Excludes portion of unearned premiums amortized into income. |
Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
Net Investment Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Investment Income | Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. |
Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Investments | Sum of the carrying amounts as of the balance sheet date of all investments. |
Increase Decrease In Deferred Policy Acquisition Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Deferred Policy Acquisition Costs | The increase (decrease) during the reporting period in the balance sheet value of capitalized sales costs that are associated with acquiring a new insurance customers. |
Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Other Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets | Amount of assets classified as other. |
Payments Of Dividends Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Ordinary Dividends, Common Stock | Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity. |
Payments To Acquire Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Short-Term Investments | The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. |
Policyholder Contract Deposits | us-gaap/2024 | 0 | 0 | monetary | I | C | Policyholder Contract Deposit | Amount of liability due to policyholder for deposit held under long-duration contract issued by insurance entity. |
Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
Treasury Stock Common Shares | us-gaap/2024 | 0 | 0 | shares | I | Treasury Stock, Common, Shares | Number of previously issued common shares repurchased by the issuing entity and held in treasury. | |
Provision For Investment Related Credit Loss Benefit Expense | 0000950170-25-061007 | 1 | 0 | monetary | D | D | Provision For Investment Related Credit Loss Benefit Expense | Provision for investment related credit loss benefit expense. |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0000950170-25-061007 | 2 | 27 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
0000950170-25-061007 | 2 | 3 | BS | 0 | H | Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss Current | us-gaap/2024 | Fixed maturity securities-held-to-maturity, at amortized cost net of allowance for credit losses of $100 and $116 in 2025 and 2024, respectively, (fair value $385,981 and $399,721 in 2025 and 2024, respectively) | 0 |
0000950170-25-061007 | 2 | 4 | BS | 0 | H | Available For Sale Securities Debt Securities | us-gaap/2024 | Fixed maturity securities-available-for-sale, at fair value (amortized cost $323,931, allowance for credit losses of $0 in 2025 and amortized cost $318,975, allowance for credit losses of $0 in 2024) | 0 |
0000950170-25-061007 | 2 | 5 | BS | 0 | H | Equity Securities Fv Ni | us-gaap/2024 | Equity securities, at fair value (cost $36,020 in 2025 and 2024) | 0 |
0000950170-25-061007 | 2 | 6 | BS | 0 | H | Marketable Securities | us-gaap/2024 | Short-term investments | 0 |
0000950170-25-061007 | 2 | 7 | BS | 0 | H | Investments | us-gaap/2024 | Total investments | 0 |
0000950170-25-061007 | 2 | 8 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
0000950170-25-061007 | 2 | 9 | BS | 0 | H | Reinsurance Recoverables | us-gaap/2024 | Amounts recoverable from reinsurers (net of allowance for credit losses of $294 and $300 in 2025 and 2024, respectively) | 0 |
0000950170-25-061007 | 2 | 10 | BS | 0 | H | Premiums Receivable At Carrying Value | us-gaap/2024 | Premiums receivable (net of allowance for credit losses of $4,129 and $4,238 in 2025 and 2024, respectively) | 0 |
0000950170-25-061007 | 2 | 11 | BS | 0 | H | Deferred Income Tax Assets Net | us-gaap/2024 | Deferred income taxes | 0 |
0000950170-25-061007 | 2 | 12 | BS | 0 | H | Accrued Investment Income Receivable | us-gaap/2024 | Accrued interest receivable | 0 |
0000950170-25-061007 | 2 | 13 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
0000950170-25-061007 | 2 | 14 | BS | 0 | H | Deferred Policy Acquisition Costs | us-gaap/2024 | Deferred policy acquisition costs | 0 |
0000950170-25-061007 | 2 | 15 | BS | 0 | H | Income Tax Receivable | us-gaap/2024 | Federal income tax recoverable | 0 |
0000950170-25-061007 | 2 | 16 | BS | 0 | H | Other Assets | us-gaap/2024 | Other assets | 0 |
0000950170-25-061007 | 2 | 17 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
0000950170-25-061007 | 2 | 20 | BS | 0 | H | Liability For Claims And Claims Adjustment Expense | us-gaap/2024 | Reserves for loss and loss adjustment expenses | 0 |
0000950170-25-061007 | 2 | 21 | BS | 0 | H | Unearned Premiums | us-gaap/2024 | Unearned premiums | 0 |
0000950170-25-061007 | 2 | 22 | BS | 0 | H | Funds Held Under Reinsurance Agreements Liability | us-gaap/2024 | Amounts held for others | 0 |
0000950170-25-061007 | 2 | 23 | BS | 0 | H | Policyholder Contract Deposits | us-gaap/2024 | Policyholder deposits | 0 |
0000950170-25-061007 | 2 | 24 | BS | 0 | H | Insurance Related Assessments | 0000950170-25-061007 | Insurance-related assessments | 0 |
0000950170-25-061007 | 2 | 25 | BS | 0 | H | Other Liabilities | us-gaap/2024 | Accounts payable and other liabilities | 0 |
0000950170-25-061007 | 2 | 26 | BS | 0 | H | Payable Investment Purchase | us-gaap/2024 | Payable for investments purchased | 0 |
0000950170-25-061007 | 2 | 29 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock: voting-$0.01 par value authorized shares-50,000,000 in 2025 and 2024; 20,733,166 shares issued and 19,050,315 shares outstanding in 2025 and 2024 | 0 |
0000950170-25-061007 | 2 | 30 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
0000950170-25-061007 | 2 | 31 | BS | 0 | H | Treasury Stock Value | us-gaap/2024 | Treasury stock, at cost (1,682,851 shares in 2025 and 2024) | 1 |
0000950170-25-061007 | 2 | 32 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated earnings | 0 |
0000950170-25-061007 | 2 | 33 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss, net | 0 |
0000950170-25-061007 | 2 | 34 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total shareholders equity | 0 |
0000950170-25-061007 | 2 | 35 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and shareholders equity | 0 |
0000950170-25-061007 | 3 | 1 | BS | 1 | H | Debt Securities Held To Maturity Allowance For Credit Loss | us-gaap/2024 | Fixed maturity securities, held-to-maturity, allowance for credit losses | 0 |
0000950170-25-061007 | 3 | 2 | BS | 1 | H | Held To Maturity Securities Fair Value | us-gaap/2024 | Fixed maturity securities, fair value | 0 |
0000950170-25-061007 | 3 | 3 | BS | 1 | H | Debt Securities Available For Sale Allowance For Credit Loss | us-gaap/2024 | Fixed maturity securities, available-for-sale, allowance for credit losses | 0 |
0000950170-25-061007 | 3 | 4 | BS | 1 | H | Available For Sale Debt Securities Amortized Cost Basis | us-gaap/2024 | Fixed maturity securities, amortized cost | 0 |
0000950170-25-061007 | 3 | 5 | BS | 1 | H | Equity Securities Fv Ni Cost | us-gaap/2024 | Equity securities, cost | 0 |
0000950170-25-061007 | 3 | 6 | BS | 1 | H | Reinsurance Recoverables Allowance | us-gaap/2024 | Amounts recoverable from reinsurers, allowance for credit losses | 0 |
0000950170-25-061007 | 3 | 7 | BS | 1 | H | Premiums Receivable Allowance For Doubtful Accounts | us-gaap/2024 | Premiums receivable, allowance for credit losses | 0 |
0000950170-25-061007 | 3 | 8 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
0000950170-25-061007 | 3 | 9 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
0000950170-25-061007 | 3 | 10 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
0000950170-25-061007 | 3 | 11 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
0000950170-25-061007 | 3 | 12 | BS | 1 | H | Treasury Stock Common Shares | us-gaap/2024 | Treasury stock, shares | 0 |
0000950170-25-061007 | 4 | 2 | IS | 0 | H | Premiums Written Gross | us-gaap/2024 | Gross premiums written | 0 |
0000950170-25-061007 | 4 | 3 | IS | 0 | H | Ceded Premiums Written | us-gaap/2024 | Ceded premiums written | 1 |
0000950170-25-061007 | 4 | 4 | IS | 0 | H | Premiums Written Net | us-gaap/2024 | Net premiums written | 0 |
0000950170-25-061007 | 4 | 5 | IS | 0 | H | Premiums Earned Net | us-gaap/2024 | Net premiums earned | 0 |
0000950170-25-061007 | 4 | 6 | IS | 0 | H | Net Investment Income | us-gaap/2024 | Net investment income | 0 |
0000950170-25-061007 | 4 | 7 | IS | 0 | H | Realized Investment Gains Losses | us-gaap/2024 | Net realized gains (losses) on investments | 0 |
0000950170-25-061007 | 4 | 8 | IS | 0 | H | Equity Securities Fv Ni Unrealized Gain Loss | us-gaap/2024 | Net unrealized gains (losses) on equity securities | 0 |
0000950170-25-061007 | 4 | 9 | IS | 0 | H | Other Income | us-gaap/2024 | Fee and other income | 0 |
0000950170-25-061007 | 4 | 10 | IS | 0 | H | Revenues | us-gaap/2024 | Total revenues | 0 |
0000950170-25-061007 | 4 | 12 | IS | 0 | H | Policyholder Benefits And Claims Incurred Net | us-gaap/2024 | Loss and loss adjustment expenses incurred | 0 |
0000950170-25-061007 | 4 | 13 | IS | 0 | H | Underwriting And Certain Other Operating Costs | 0000950170-25-061007 | Underwriting and certain other operating costs | 0 |
0000950170-25-061007 | 4 | 14 | IS | 0 | H | Insurance Commissions | us-gaap/2024 | Commissions | 0 |
0000950170-25-061007 | 4 | 15 | IS | 0 | H | Labor And Related Expense | us-gaap/2024 | Salaries and benefits | 0 |
0000950170-25-061007 | 4 | 16 | IS | 0 | H | Policyholder Dividends | us-gaap/2024 | Policyholder dividends | 0 |
0000950170-25-061007 | 4 | 17 | IS | 0 | H | Provision For Investment Related Credit Loss Benefit Expense | 0000950170-25-061007 | Provision for investment related credit loss benefit | 0 |
0000950170-25-061007 | 4 | 18 | IS | 0 | H | Benefits Losses And Expenses | us-gaap/2024 | Total expenses | 0 |
0000950170-25-061007 | 4 | 19 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Income before income taxes | 0 |
0000950170-25-061007 | 4 | 20 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax expense | 0 |
0000950170-25-061007 | 4 | 21 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
0000950170-25-061007 | 4 | 23 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic | 0 |
0000950170-25-061007 | 4 | 24 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted | 0 |
0000950170-25-061007 | 4 | 26 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic | 0 |
0000950170-25-061007 | 4 | 27 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted | 0 |
0000950170-25-061007 | 4 | 28 | IS | 0 | H | Common Stock Dividends Per Share Declared | us-gaap/2024 | Cash dividends declared per common share | 0 |
0000950170-25-061007 | 5 | 1 | CI | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
0000950170-25-061007 | 5 | 3 | CI | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Unrealized gain (loss) on debt securities, net of tax | 0 |
0000950170-25-061007 | 5 | 4 | CI | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive income | 0 |
0000950170-25-061007 | 6 | 10 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning Balance | 0 |
0000950170-25-061007 | 6 | 11 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Beginning Balance, Shares | 0 |
0000950170-25-061007 | 6 | 12 | EQ | 0 | H | Treasury Stock Common Shares | us-gaap/2024 | Beginning Balance, Shares | 1 |
0000950170-25-061007 | 6 | 14 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net income | 0 |
0000950170-25-061007 | 6 | 16 | EQ | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Change in unrealized losses on debt securities, net of tax | 0 |
0000950170-25-061007 | 6 | 17 | EQ | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive income | 0 |
0000950170-25-061007 | 6 | 18 | EQ | 0 | H | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | us-gaap/2024 | Share-based compensation | 0 |
0000950170-25-061007 | 6 | 19 | EQ | 0 | H | Dividends Common Stock | us-gaap/2024 | Dividends to shareholders | 1 |
0000950170-25-061007 | 6 | 20 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending Balance | 0 |
0000950170-25-061007 | 6 | 21 | EQ | 0 | H | Common Stock Shares Outstanding | us-gaap/2024 | Ending Balance, Shares | 0 |
0000950170-25-061007 | 6 | 22 | EQ | 0 | H | Treasury Stock Common Shares | us-gaap/2024 | Ending Balance, Shares | 1 |
0000950170-25-061007 | 7 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net income | 0 |
0000950170-25-061007 | 7 | 4 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation | 0 |
0000950170-25-061007 | 7 | 5 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Net amortization of investments | 1 |
0000950170-25-061007 | 7 | 6 | CF | 0 | H | Change In Investment Related Allowance For Credit Losses | 0000950170-25-061007 | Change in investment related allowance for credit losses | 0 |
0000950170-25-061007 | 7 | 7 | CF | 0 | H | Deferred Income Tax Expense Benefit | us-gaap/2024 | Deferred income taxes | 0 |
0000950170-25-061007 | 7 | 8 | CF | 0 | H | Realized Investment Gains Losses | us-gaap/2024 | Net realized (gains) losses on investments | 1 |
0000950170-25-061007 | 7 | 9 | CF | 0 | H | Equity Securities Fv Ni Unrealized Gain Loss | us-gaap/2024 | Net unrealized (gains) losses on equity securities | 1 |
0000950170-25-061007 | 7 | 10 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation | 0 |
0000950170-25-061007 | 7 | 12 | CF | 0 | H | Increase Decrease In Premiums Receivable | us-gaap/2024 | Premiums receivable, net | 1 |
0000950170-25-061007 | 7 | 13 | CF | 0 | H | Increase Decrease In Accrued Investment Income Receivable | us-gaap/2024 | Accrued interest receivable | 1 |
0000950170-25-061007 | 7 | 14 | CF | 0 | H | Increase Decrease In Deferred Policy Acquisition Costs | us-gaap/2024 | Deferred policy acquisition costs | 1 |
0000950170-25-061007 | 7 | 15 | CF | 0 | H | Increase Decrease In Other Operating Assets | us-gaap/2024 | Other assets | 1 |
0000950170-25-061007 | 7 | 16 | CF | 0 | H | Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve | us-gaap/2024 | Reserves for loss and loss adjustment expenses | 0 |
0000950170-25-061007 | 7 | 17 | CF | 0 | H | Increase Decrease In Unearned Premiums | us-gaap/2024 | Unearned premiums | 0 |
0000950170-25-061007 | 7 | 18 | CF | 0 | H | Increase Decrease Reinsurance Balances | 0000950170-25-061007 | Reinsurance balances | 0 |
0000950170-25-061007 | 7 | 19 | CF | 0 | H | Increase Decrease Amounts Held For Others And Policyholder Deposits | 0000950170-25-061007 | Amounts held for others and policyholder deposits | 0 |
0000950170-25-061007 | 7 | 20 | CF | 0 | H | Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | us-gaap/2024 | Federal income taxes recoverable | 0 |
0000950170-25-061007 | 7 | 21 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and other liabilities | 0 |
0000950170-25-061007 | 7 | 22 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash provided by (used in) operating activities | 0 |
0000950170-25-061007 | 7 | 24 | CF | 0 | H | Payments To Acquire Held To Maturity Securities | us-gaap/2024 | Purchases of investments held-to-maturity | 1 |
0000950170-25-061007 | 7 | 25 | CF | 0 | H | Payments To Acquire Available For Sale Securities Debt | us-gaap/2024 | Purchases of investments available-for-sale | 1 |
0000950170-25-061007 | 7 | 26 | CF | 0 | H | Payments To Acquire Short Term Investments | us-gaap/2024 | Purchases of short-term investments | 1 |
0000950170-25-061007 | 7 | 27 | CF | 0 | H | Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities | us-gaap/2024 | Proceeds from maturities of investments held-to-maturity | 0 |
0000950170-25-061007 | 7 | 28 | CF | 0 | H | Proceeds From Sale And Maturity Of Available For Sale Securities | us-gaap/2024 | Proceeds from sales and maturities of investments available-for-sale | 0 |
0000950170-25-061007 | 7 | 29 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
0000950170-25-061007 | 7 | 30 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by (used in) investing activities | 0 |
0000950170-25-061007 | 7 | 32 | CF | 0 | H | Finance Lease Principal Payments | us-gaap/2024 | Finance lease purchases | 1 |
0000950170-25-061007 | 7 | 33 | CF | 0 | H | Payments Of Dividends Common Stock | us-gaap/2024 | Dividends to shareholders | 1 |
0000950170-25-061007 | 7 | 34 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash used in financing activities | 0 |
0000950170-25-061007 | 7 | 35 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Change in cash and cash equivalents | 0 |
0000950170-25-061007 | 7 | 36 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
0000950170-25-061007 | 7 | 37 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |